Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform Clears House, But Provisions On PTO Fees, Patent Term Extension Differ From Senate

This article was originally published in The Pink Sheet Daily

Executive Summary

The Medicines Company and the Appropriations Committee score victories as the House clears the bill by a vote of 304 to 117.
Advertisement

Related Content

Patent Reform: Senate May Amend Two Provisions In House Bill
Patent Reform: Senate May Amend Two Provisions In House Bill
PTO Seeks Early Public Input On Patent Reform Implementation
PTO Seeks Early Public Input On Patent Reform Implementation
Patent Reform Bill Stumbles As Compromise On PTO Fee Diversion Divides House
Patent Reform Bill Stumbles As Compromise On PTO Fee Diversion Divides House
The Medicines Company Is Almost Ready To Celebrate Angiomax Patent Term Extension

Topics

Advertisement
UsernamePublicRestriction

Register

PS072415

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel